You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR HEPLISAV-B


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for HEPLISAV-B

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03934736 ↗ HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis Active, not recruiting Dynavax Technologies Corporation Phase 1 2019-04-29 This is an open-label, single arm study design to evaluate HEPLISAV-B® in adults with ESRD who are initiating or undergoing hemodialysis.
NCT04843852 ↗ TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B Not yet recruiting University of Maryland, Baltimore Phase 1 2021-12-01 Unmethylated cystine-guanosine dinucleotide (CpG) motifs are pathogen-associated molecular patterns (PAMPs) associated with bacterial and viral-derived DNA that activate the innate and humoral immunity via toll-like receptor 9. This is a randomized controlled pilot study evaluating the clinical and immune correlates of a seroprotective immune response against a CpG-adjuvanted vaccine for hepatitis B.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for HEPLISAV-B

Condition Name

Condition Name for HEPLISAV-B
Intervention Trials
End Stage Renal Disease on Dialysis (Diagnosis) 1
Hepatitis B 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for HEPLISAV-B
Intervention Trials
Hepatitis B 2
Hepatitis 1
Kidney Failure, Chronic 1
Kidney Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for HEPLISAV-B

Trials by Country

Trials by Country for HEPLISAV-B
Location Trials
United States 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for HEPLISAV-B
Location Trials
Virginia 2
Maryland 1
Wisconsin 1
Texas 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for HEPLISAV-B

Clinical Trial Phase

Clinical Trial Phase for HEPLISAV-B
Clinical Trial Phase Trials
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for HEPLISAV-B
Clinical Trial Phase Trials
Not yet recruiting 1
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for HEPLISAV-B

Sponsor Name

Sponsor Name for HEPLISAV-B
Sponsor Trials
Dynavax Technologies Corporation 1
University of Maryland, Baltimore 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for HEPLISAV-B
Sponsor Trials
Industry 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.